Literature DB >> 11840343

Regulation of p73 by c-Abl through the p38 MAP kinase pathway.

Ricardo Sanchez-Prieto1, Victor Javier Sanchez-Arevalo, Joan-Marc Servitja, J Silvio Gutkind.   

Abstract

p73 is a novel member of the p53 family of tumor suppressor proteins which is involved in cellular differentiation, tumor suppression, and the response to genotoxic stress. The molecular mechanisms regulating p73 activity are still poorly understood. Recently, p73 was found to be a target of the enzymatic activity of c-Abl, a non-receptor tyrosine kinase that potently activated in response to DNA damage. Here, we present evidence that c-Abl induces the phosphorylation of p73 in threonine residues adjacent to prolines, and that the p38 MAP kinase pathway mediates this response. Furthermore, we found that activation of p38 is sufficient to enhance the stability of p73, and that the transcriptional activation of p73 by c-Abl requires the activity of p38. These findings indicate that members of the MAP kinases superfamily of signaling molecules can regulate p73, and support a role for the p38 MAP kinase in a novel biochemical pathway by which c-Abl regulates this p53-related molecule.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11840343     DOI: 10.1038/sj.onc.1205134

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin.

Authors:  Hideki Shimodaira; Atsuko Yoshioka-Yamashita; Richard D Kolodner; Jean Y J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

2.  p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.

Authors:  Marshall Urist; Tomoaki Tanaka; Masha V Poyurovsky; Carol Prives
Journal:  Genes Dev       Date:  2004-12-15       Impact factor: 11.361

Review 3.  Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?

Authors:  Peter E Shaw
Journal:  EMBO Rep       Date:  2007-01       Impact factor: 8.807

Review 4.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

5.  Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73.

Authors:  Y K Satija; S Das
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

6.  AMPK couples p73 with p53 in cell fate decision.

Authors:  Y Adamovich; J Adler; V Meltser; N Reuven; Y Shaul
Journal:  Cell Death Differ       Date:  2014-05-30       Impact factor: 15.828

Review 7.  The p53 family and programmed cell death.

Authors:  E C Pietsch; S M Sykes; S B McMahon; M E Murphy
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

8.  Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death.

Authors:  Stefania Gonfloni; Lucia Di Tella; Sara Caldarola; Stefano M Cannata; Francesca G Klinger; Claudia Di Bartolomeo; Maurizio Mattei; Eleonora Candi; Massimo De Felici; Gerry Melino; Gianni Cesareni
Journal:  Nat Med       Date:  2009-09-27       Impact factor: 53.440

9.  A gene signature-based approach identifies mTOR as a regulator of p73.

Authors:  Jennifer M Rosenbluth; Deborah J Mays; Maria F Pino; Luo Jia Tang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

10.  Dual regulation of Myc by Abl.

Authors:  V J Sanchez-Arévalo Lobo; M Doni; A Verrecchia; S Sanulli; G Fagà; A Piontini; M Bianchi; M Conacci-Sorrell; G Mazzarol; V Peg; J H Losa; P Ronchi; M Ponzoni; R N Eisenman; C Doglioni; B Amati
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.